PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
37.68
+1.85 (5.16%)
Last updated: Jul 14, 2025
SHE:301230 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 568.65 | 529.95 | 480.48 | 472.12 | 446.44 | 278.5 | Upgrade |
Other Revenue | 14.52 | 14.52 | 9.24 | 6.76 | 1.77 | 4.49 | Upgrade |
583.17 | 544.47 | 489.72 | 478.88 | 448.21 | 282.99 | Upgrade | |
Revenue Growth (YoY) | 16.86% | 11.18% | 2.26% | 6.84% | 58.38% | 15.41% | Upgrade |
Cost of Revenue | 431.44 | 413.89 | 350.61 | 304.46 | 278 | 166.56 | Upgrade |
Gross Profit | 151.74 | 130.58 | 139.11 | 174.42 | 170.22 | 116.43 | Upgrade |
Selling, General & Admin | 96.66 | 89.18 | 73.59 | 80.17 | 61.87 | 43.98 | Upgrade |
Research & Development | 44.71 | 47.26 | 37.34 | 32.65 | 17.14 | 11.67 | Upgrade |
Other Operating Expenses | 2.75 | 1.76 | 1.24 | 1.66 | 1.77 | 0.91 | Upgrade |
Operating Expenses | 146.38 | 139.48 | 112.46 | 114.17 | 83.24 | 55.81 | Upgrade |
Operating Income | 5.36 | -8.9 | 26.64 | 60.25 | 86.98 | 60.62 | Upgrade |
Interest Expense | -9.04 | -9.28 | -5.46 | -4.79 | -2.53 | -1.22 | Upgrade |
Interest & Investment Income | 4.42 | 6.57 | 6.16 | 3.49 | 2.42 | 2.01 | Upgrade |
Currency Exchange Gain (Loss) | 5.37 | 5.37 | 0.7 | 9.44 | -2.56 | -9.16 | Upgrade |
Other Non Operating Income (Expenses) | -0.22 | -0.2 | -0.18 | -0.16 | -0.14 | -0.21 | Upgrade |
EBT Excluding Unusual Items | 5.89 | -6.44 | 27.86 | 68.23 | 84.17 | 52.05 | Upgrade |
Gain (Loss) on Sale of Investments | 5.55 | 4.97 | 5.58 | -0.1 | 0.4 | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.06 | - | 0.01 | -0.07 | 0.05 | - | Upgrade |
Asset Writedown | -4.55 | -0.29 | -0.71 | - | -0.49 | -0.3 | Upgrade |
Other Unusual Items | 5.91 | 5.29 | 4.02 | 4.86 | 2.1 | 3.46 | Upgrade |
Pretax Income | 12.74 | 3.54 | 36.76 | 72.92 | 86.23 | 55.22 | Upgrade |
Income Tax Expense | -12.65 | -13.55 | -0.86 | 5.75 | 12.66 | 6.52 | Upgrade |
Net Income | 25.39 | 17.08 | 37.62 | 67.18 | 73.58 | 48.69 | Upgrade |
Net Income to Common | 25.39 | 17.08 | 37.62 | 67.18 | 73.58 | 48.69 | Upgrade |
Net Income Growth | -2.39% | -54.59% | -44.00% | -8.70% | 51.11% | 3.04% | Upgrade |
Shares Outstanding (Basic) | 145 | 142 | 139 | 111 | 105 | 103 | Upgrade |
Shares Outstanding (Diluted) | 145 | 142 | 139 | 111 | 105 | 103 | Upgrade |
Shares Change (YoY) | 7.90% | 2.17% | 26.04% | 5.66% | 1.58% | 1.86% | Upgrade |
EPS (Basic) | 0.18 | 0.12 | 0.27 | 0.61 | 0.70 | 0.47 | Upgrade |
EPS (Diluted) | 0.18 | 0.12 | 0.27 | 0.61 | 0.70 | 0.47 | Upgrade |
EPS Growth | -9.54% | -55.56% | -55.57% | -13.59% | 48.85% | 1.18% | Upgrade |
Free Cash Flow | -27.34 | -28.54 | -227.41 | -24.67 | 13.01 | 20.94 | Upgrade |
Free Cash Flow Per Share | -0.19 | -0.20 | -1.63 | -0.22 | 0.12 | 0.20 | Upgrade |
Dividend Per Share | 0.430 | 0.430 | 0.330 | 0.275 | - | - | Upgrade |
Dividend Growth | 30.30% | 30.30% | 20.13% | - | - | - | Upgrade |
Gross Margin | 26.02% | 23.98% | 28.41% | 36.42% | 37.98% | 41.14% | Upgrade |
Operating Margin | 0.92% | -1.63% | 5.44% | 12.58% | 19.41% | 21.42% | Upgrade |
Profit Margin | 4.35% | 3.14% | 7.68% | 14.03% | 16.42% | 17.21% | Upgrade |
Free Cash Flow Margin | -4.69% | -5.24% | -46.44% | -5.15% | 2.90% | 7.40% | Upgrade |
EBITDA | 32.54 | 17 | 47.41 | 76.6 | 99.57 | 72.38 | Upgrade |
EBITDA Margin | 5.58% | 3.12% | 9.68% | 16.00% | 22.22% | 25.58% | Upgrade |
D&A For EBITDA | 27.18 | 25.9 | 20.77 | 16.35 | 12.59 | 11.76 | Upgrade |
EBIT | 5.36 | -8.9 | 26.64 | 60.25 | 86.98 | 60.62 | Upgrade |
EBIT Margin | 0.92% | -1.63% | 5.44% | 12.58% | 19.41% | 21.42% | Upgrade |
Effective Tax Rate | - | - | - | 7.88% | 14.68% | 11.82% | Upgrade |
Revenue as Reported | 583.17 | 544.47 | 489.72 | 478.88 | 448.21 | 282.99 | Upgrade |
Advertising Expenses | - | 0.21 | 0.11 | 0.43 | 0.03 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.